Ovations for the Cure Arms Women with Education to Battle Ovarian Cancer Nonprofit Hosts 2nd Annual Symposium

Share Article

Sold-out symposium provides ovarian cancer patients with latest medical treatments

Ovations for the Cure, a non-profit organization dedicated to the relentless pursuit of a cure for ovarian cancer, educated over 225 ovarian cancer patients and caregivers about the latest medical breakthroughs and treatment options at their 2nd Annual Learning for Living with Ovarian Cancer Symposium at the Four Seasons Hotel in Boston, MA on September 6th.

Presented during National Ovarian Cancer Awareness month, the symposium included oncologists from around the country, including Dr. Ursula Matulonis, Ovations for the Cure's Medical Advisor and Director and Program Manager of Medical Gynecological Oncology at Dana-Farber Cancer Institute.

"The Learning for Living Symposium provides ovarian cancer patients from across the country the opportunity to learn about and join the leading clinical trials in the fight against this disease," said Dr. Ursula Matulonis. "Ovations for the Cure's educational initiatives increase patient enrollment and awareness surrounding ovarian cancer medical research, which will help find a cure for the deadliest gynecological cancer."

Additional medical professionals presenting at the symposium included: Ronny Drapkin, M.D., Ph.D. Assistant Professor of Pathology at Harvard Medical School; Marsha A. Moses, Ph.D. Professor in the Department of Surgery at Harvard Medical School and the Vascular Biology Program at Children's Hospital Boston; Harriet Berman, Ph.D., Executive Vice President for Clinical Programs at The Wellness Community; Carolyn Krasner, M.D., Instructor in Medicine and Disease Program Leader, Medical Gynecologic Oncology at Massachusetts General Hospital; and Robert J. Morgan, M.D., Professor of Medical Oncology, Division of Medical Oncology and Therapeutics Research at City of Hope Cancer Center in Los Angeles, California.

Sponsored by Genentech, The Wellness Community - Greater Boston, Friends of Mel Foundation, and Novartis, the symposium presented patients with valuable medical updates and one-on-one time with individual experts to learn about research surrounding noninvasive diagnostic urine tests for different cancers, intraperitoneal therapy for ovarian cancer, development of new therapeutic treatment agents, biological functions of BRIP1, which may be the product of a cancer gene, and ovarian cancer biomarkers.

"Only a few years ago there were few, if any, handouts and educational programs on ovarian cancer," said Susan Patterson, Manager of Patient Awareness Education and Outreach for Ovations for the Cure. "Events such as the Annual Learning for Living Symposium provide women battling this disease with the latest medical information available to make educated decisions about different treatment and therapeutic options."

About Ovations for the Cure
Ovations for the Cure, a 501(c)(3) non-profit organization, is dedicated to the relentless pursuit of a cure for ovarian cancer. Since its inception in 2006, Ovations for the Cure has dedicated over $1 million to various ovarian cancer research initiatives such as Dana-Farber Cancer Institute, Children's Hospital Boston, City of Hope, University of Pennsylvania, and Brigham and Woman's Hospital. The Foundation spreads awareness of the most deadly gynecological disease through national events including the renowned Happy Feet Program, fashion shows with celebrity designers Stuart Weitzman and Carmen Marc Valvo, regional golf outings, 5k runs/walks, and various other initiatives. For more information about Ovations, please visit http://www.ovationsforthecure.org.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Hopkins

Email >